Initiating gender-affirming hormones for transgender and non-binary people: A qualitative study of providers’ perspectives on requiring mental health evaluations

OBJECTIVE: Gender-affirming hormones (GAH)—the use of sex hormones to induce desired secondary sex characteristics in transgender individuals—is vital healthcare for many transgender people. Among prescribers of GAH, there is debate regarding the value of a universal requirement for an evaluation by...

Descripción completa

Detalles Bibliográficos
Autores principales: Stroumsa, Daphna, Minadeo, Leah A., Maksutova, Mariam, Moravek, Molly B., Stephenson, Rob, Pfeiffer, Paul N., Wu, Justine P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387802/
https://www.ncbi.nlm.nih.gov/pubmed/35980962
http://dx.doi.org/10.1371/journal.pone.0271785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387802/
https://www.ncbi.nlm.nih.gov/pubmed/35980962
http://dx.doi.org/10.1371/journal.pone.0271785

Ejemplares similares